New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

In many recurrent and/or metastatic cancers, the advent of immunotherapy opens up new scenarios of treatment response, with new phenomena, such as pseudoprogression and hyperprogression. Because of this, different immune-related response criteria have been developed, and new therapeutic strategies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberti, Andrea, Lorini, Luigi, Ravanelli, Marco, Perri, Francesco, Vinches, Marie, Rondi, Paolo, Romani, Chiara, Bossi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228441/
https://www.ncbi.nlm.nih.gov/pubmed/35746493
http://dx.doi.org/10.3390/vaccines10060885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228441/
https://www.ncbi.nlm.nih.gov/pubmed/35746493
http://dx.doi.org/10.3390/vaccines10060885

Ejemplares similares